Table 1 The relationship of MSI2 with ZEB1, E-cad, Vimentin and c-Myc expression in clinical samples
From: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling
Parameters | CRT | Spearman ranks | P | ||
|---|---|---|---|---|---|
Low (24) | High (50) | ||||
ZEB1 | Negative (35) | 16 | 19 | 0.269 | 0.021 |
Positive (39) | 8 | 31 | Â | Â | |
E-cad | Abnormal (45) | 10 | 35 | −0.272 | 0.019 |
Normal (29) | 14 | 15 | Â | Â | |
c-Myc | Negative (36) | 16 | 20 | 0.250 | 0.032 |
Positive (38) | 8 | 30 | Â | Â | |
Vimentin | Negative (52) | 20 | 32 | 0.198 | 0.089 |
Positive (22) | 4 | 18 | Â | Â | |